SMARCD3 Promotes Epithelial-Mesenchymal Transition in Gastric Cancer by Integrating PI3K-AKT and WNT/β-Catenin Pathways.

Cancers (Basel) · 2025 · PMC12607331 · PMID 41228321

Europe PMC DOI

hedged sentence

0.1900

closest p · 3.8× alpha

0.1900

boldest claim

The sentences

did not reach statistical significancep = 0.19not close (p > 0.1)

The number of SMARCD3-overexpressing cells decreased (13 ± 2.65 in group #1; 16 ± 1 in group #2), but it increased after LY294002 treatment, though this increase did not reach statistical significance (20.67 ± 1.53, p = 0.19 in group #1; 25.33 ± 5.86, p = 0.08 in group #2).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.